Tag: Drug Approvals
FDA Approves First Tx for Disease Linked to Stem Cell Transplant
Hepatic veno-occlusive disease is rare, but fatal
FDA Approves Cinqair for Severe Asthma
Lab-developed interleukin-5 antagonist monoclonal antibody helps reduce blood levels of eosinophils
FDA Approves Anthim for Treating Inhalation Anthrax
Anthim, combined with certain antibacterial drugs, designed to neutralize anthrax toxins
FDA Approves Xalkori for Rare Genetic Form of Lung Cancer
Drug approval expanded to include patients with ROS1-positive NSCLC
FDA Approves Briviact for Partial Onset Seizures
Drug sanctioned for epilepsy patients aged 16 and older
FDA Approves Zepatier for Chronic Hepatitis C
Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections
FDA Approves Halaven for Advanced Liposarcoma
FDA says it's first liposarcoma drug to improve survival
FDA Approves Device for Diabetic Foot Ulcers
The device, first approved to treat burns, is made of silicone, cow collagen, and shark cartilage
FDA Approves Zurampic for the Treatment of Gout
Drug helps control blood levels of uric acid
FDA Approves Uptravi for Pulmonary Arterial Hypertension
Drug found to limit worsening of the disease and reduce the need for hospitalization
